London
Over two weeks, the course will cover the whole drug-development value chain
Dr. Khalid Islam has extensive experience in the pharmaceutical and biotechnology industry and the company believes he can lead them to great successes
Biotechnology firm Aelix Therapeutics has received funding from Ysios Capital, Caixa Capital Risc and Johnson & Johnson Innovation
Researchers have also presented the first platform for atomic-level simulation of nucleic acids
The company raised €234,310 from 115 investors through the Crowdcube platform, which is shaping up as the funding alternative in biotechnology
The company, which specializes in drug development for rare or minority diseases without treatment, has received €19.4
